Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00003619
What this trial is testing

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+1 more
Drexel University College of Medicine
Testing effectiveness (Phase 2)Study completedNCT01252667
What this trial is testing

Clofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell Transplant

Who this might be right for
Acute Myeloid Leukemia
Fred Hutchinson Cancer Center 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT05393804
What this trial is testing

Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 24
Early research (Phase 1)Study completedNCT00070616
What this trial is testing

Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support

Who this might be right for
LeukemiaLymphomaMyeloma
Swedish Orphan Biovitrum 25
Testing effectiveness (Phase 2)Study completedNCT00003944
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Fox Chase Cancer Center 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT05346809
What this trial is testing

Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma

Who this might be right for
LymphomaMultiple MyelomaNon-Hodgkin Lymphoma+1 more
Divaya Bhutani 8
Testing effectiveness (Phase 2)Study completedNCT01818284
What this trial is testing

Plerixafor for Stem Cell Mobilization in Normal Donors

Who this might be right for
Blood And Marrow Transplantation
M.D. Anderson Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT00241358
What this trial is testing

Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Myelogenous, ChronicLeukemia, Lymphoblastic, Acute+5 more
Washington University School of Medicine 92
Testing effectiveness (Phase 2)Study completedNCT03317899
What this trial is testing

Stem Cell Transplant With or Without Tbo-filgrastim in Treating Patients With Multiple Myeloma or Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaPlasma Cell Myeloma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 77
Testing effectiveness (Phase 2)Study completedNCT00823316
What this trial is testing

Safety and Efficacy Study of Umbilical Cord Blood-Drived Mesenchymal Stem Cells to Promote Engraftment of Unrelated Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Leukemia
Medipost Co Ltd. 10
Testing effectiveness (Phase 2)Looking for participantsNCT05636787
What this trial is testing

Clinical Trial Investigating the Chemotherapeutic Compound Treosulfan (Trecondi® Ideogen) in Myeloma Patients

Who this might be right for
Multiple Myeloma
Insel Gruppe AG, University Hospital Bern 120
Large-scale testing (Phase 3)Study completedNCT03652064
What this trial is testing

A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 395
Testing effectiveness (Phase 2)Study completedNCT00048412
What this trial is testing

Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H

Who this might be right for
Myelodysplastic DisordersLeukemiaMultiple Myeloma+2 more
Baylor College of Medicine 40
Early research (Phase 1)Active Not RecruitingNCT05823571
What this trial is testing

Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients

Who this might be right for
Leukemia, AcuteMyelodysplastic SyndromesMyelomonocytic Leukemia, Chronic+5 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 32
Testing effectiveness (Phase 2)WithdrawnNCT00024128
What this trial is testing

Peripheral Stem Cell Transplantation Followed By Infusion of White Blood Cells in Treating Patients With AIDS-Related Lymphoma

Who this might be right for
Lymphoma
AIDS Malignancy Consortium
Early research (Phase 1)Study completedNCT01758328
What this trial is testing

Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 29
Testing effectiveness (Phase 2)Study completedNCT02780609
What this trial is testing

Selinexor Plus High-Dose Melphalan (HDM) Before Autologous Hematopoietic Cell Transplantation for Multiple Myeloma

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 22
Not applicableStudy completedNCT03654404
What this trial is testing

A Proof-of-Concept Trial of a Positive Psychology Intervention for Allogeneic Stem Cell Transplant Patients

Who this might be right for
Hematologic MalignancyHematopoietic/Lymphoid CancerBlood Cancer
Brigham and Women's Hospital 29
Testing effectiveness (Phase 2)Study completedNCT00730314
What this trial is testing

Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells

Who this might be right for
Sickle Cell DiseaseThalassemiaAnemia+9 more
Children's Hospital Los Angeles 25
Testing effectiveness (Phase 2)Study completedNCT00867529
What this trial is testing

Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma

Who this might be right for
B-cell Adult Acute Lymphoblastic LeukemiaB-cell Childhood Acute Lymphoblastic LeukemiaB-cell Chronic Lymphocytic Leukemia+35 more
Fred Hutchinson Cancer Center 63
Next Page